Altimmune, Inc. (ALT) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts ALT Hot Sheet
Join SI Premium – FREE
Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
- Iran Says Hormuz To Close, Citing Ceasefire Violation- Tasnim
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
